Chester County News and Community Website
PHILADELPHIA, PA — Medicus Pharma (Nasdaq: MDCX) has advanced its SkinJect® treatment into registrational development for Gorlin Syndrome, a rare genetic disorder that causes recurring skin cancers and often requires …
Medicus Pharma Seeks FDA Path for Rare Skin Cancer Disorder Read More PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported additional Phase 2 trial data showing higher-dose treatment with its experimental SkinJect therapy produced stronger response rates in patients with nodular …
Medicus Pharma (Nasdaq: MDCX) Advances Lead Skin Cancer Regimen Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) said it will present Phase 2 exploratory data on its investigational skin cancer treatment VP-315 at the 2026 Society for Investigative …
Verrica to Present Phase 2 Data on Skin Cancer Therapy at SID Meeting Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a dissolvable microneedle patch designed to deliver chemotherapy directly into basal cell …
Medicus Pharma Reports Phase 2 Results for Skin Cancer Patch Read More
EXTON, PA — SkinCure Oncology has launched its cutting-edge Image-Guided Superficial Radiation Therapy (Image-Guided SRT) in Chester County, offering a noninvasive alternative for treating nonmelanoma skin cancers. This innovative therapy is …
SkinCure Oncology Brings Advanced Skin Cancer Treatment to Chester County Read More